Gene Therapy - Table of Contents alert Volume 20 Issue 12

Advertisement We've always made the highest quality RNA, now we also make the best mRNA. GMP Manufacturing Affordable Custom Synthesis Genome Editing & Manipulation Tools Gene Replacement, Immunotherapy & Delivery Optimization Stocked Stem Cell Reprogramming Factors Contact us to discuss your path to pharmaceutical GMP manufacturing. www.trilinkbiotech.com/mRNA TABLE OF CONTENTS Volume 20, Issue 12 (December 2013) In this issue Review Mini Review Original Articles Short Communications Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Nature Collections TCGA pan-cancer analysis The Cancer Genome Atlas Pan-cancer initiative examines the similarities and differences among the genomic and cellular alterations found in the first dozen tumor types to be profiled by TCGA. This first look across cancer offers new tools in genomics and bioinformatics and the prospect of repurposing targeted therapies directed by the molecular pathology of the tumors in addition to their clinical classification. Access the Collection and accompanying Podcast, FREE at: www.nature.com/tcga  Produced with support from Illumina  Review Top In vivo reprogramming in inflammatory bowel disease A Wagnerova and R Gardlik Gene Ther 2013 20: 1111-1118; advance online publication, September 12, 2013; 10.1038/gt.2013.43 Abstract | Full Text Mini Review Top Gene therapy for deafness D C Kohrman and Y Raphael Gene Ther 2013 20: 1119-1123; advance online publication, July 18, 2013; 10.1038/gt.2013.39 Abstract | Full Text Original Articles Top PEGylated helper-dependent adenoviral vector expressing human Apo A-I for gene therapy in LDLR-deficient mice E Leggiero, D Astone, V Cerullo, B Lombardo, C Mazzaccara, G Labruna, L Sacchetti, F Salvatore, M Croyle and L Pastore Gene Ther 2013 20: 1124-1130; advance online publication, July 25, 2013; 10.1038/gt.2013.38 Abstract | Full Text Efficacy of oncolytic adenovirus expressing suicide genes and interleukin-12 in preclinical model of prostate cancer S O Freytag, K N Barton and Y Zhang Gene Ther 2013 20: 1131-1139; advance online publication, July 11, 2013; 10.1038/gt.2013.40 Abstract | Full Text Inhibition of hepatic fibrosis with artificial microRNA using ultrasound and cationic liposome-bearing microbubbles D Yang, Y-H Gao, K-B Tan, Z-X Zuo, W-X Yang, X Hua, P-J Li, Y Zhang and G Wang Gene Ther 2013 20: 1140-1148; advance online publication, August 22, 2013; 10.1038/gt.2013.41 Abstract | Full Text Improved axonal regeneration of transected spinal cord mediated by multichannel collagen conduits functionalized with neurotrophin-3 gene L Yao, W Daly, B Newland, S Yao, W Wang, B K K Chen, N Madigan, A Windebank and A Pandit Gene Ther 2013 20: 1149-1157; advance online publication, July 25, 2013; 10.1038/gt.2013.42 Abstract | Full Text Pseudotyping the adenovirus serotype 5 capsid with both the fibre and penton of serotype 35 enhances vascular smooth muscle cell transduction OPEN A L Parker, K M White, C A Lavery, J Custers, S N Waddington and A H Baker Gene Ther 2013 20: 1158-1164; advance online publication, September 5, 2013; 10.1038/gt.2013.44 Abstract | Full Text Improved therapeutic effect on malignant glioma with adenoviral suicide gene therapy combined with temozolomide H Stedt, H Samaranayake, J Pikkarainen, A M Määttä, L Alasaarela, K Airenne and S Ylä-Herttuala Gene Ther 2013 20: 1165-1171; advance online publication, September 26, 2013; 10.1038/gt.2013.46 Abstract | Full Text The MRI contrast agent gadoteridol enhances distribution of rAAV1 in the rat hippocampus R Hullinger, J Ugalde, L Purón-Sierra, S Osting and C Burger Gene Ther 2013 20: 1172-1177; advance online publication, September 19, 2013; 10.1038/gt.2013.47 Abstract | Full Text Adeno-associated virus type 6 is retrogradely transported in the non-human primate brain W San Sebastian, L Samaranch, G Heller, A P Kells, J Bringas, P Pivirotto, J Forsayeth and K S Bankiewicz Gene Ther 2013 20: 1178-1183; advance online publication, September 26, 2013; 10.1038/gt.2013.48 Abstract | Full Text Short Communications Top AAV-encoded OTC activity persisting to adulthood following delivery to newborn spfash mice is insufficient to prevent shRNA-induced hyperammonaemia S C Cunningham, C Y Kok, A Spinoulas, K H Carpenter and I E Alexander Gene Ther 2013 20: 1184-1187; advance online publication, October 10, 2013; 10.1038/gt.2013.51 Abstract | Full Text Liver-directed adeno-associated virus serotype 8 gene transfer rescues a lethal murine model of citrullinemia type 1 R J Chandler, T N Tarasenko, K Cusmano-Ozog, Q Sun, V R Sutton, C P Venditti and P J McGuire Gene Ther 2013 20: 1188-1191; advance online publication, October 17, 2013; 10.1038/gt.2013.53 Abstract | Full Text Corrigendum Top PEGylated helper-dependent adenoviral vector expressing human Apo A-I for gene therapy in LDLR-deficient mice E Leggiero, D Astone, V Cerullo, B Lombardo, C Mazzaccara, G Labruna, L Sacchetti, F Salvatore, M Croyle and L Pastore Gene Ther 2013 20: 1192; 10.1038/gt.2013.45 Full Text Advertisement Read the most requested articles from Genes & Immunity in 2013.  Common and specific signatures of gene expression and protein?protein interactions in autoimmune diseases   Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment  Visit www.nature.com/gene to sign up for the monthly e-Alert or to submit your research.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.